BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity...
BioPharma
South Korea – A Biopharma Innovation Hub With 113% Growth
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value...
BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End to His Tenure
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job...
Drug Research
Resistance-Evasive Antibiotic for Genes-Free Clinics
In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop...
News
Why Custom Tin Containers Are Reshaping Medicine & Supplement Packaging
In an industry driven by both compliance and consumer confidence, pharmaceutical and nutraceutical brands are increasingly turning toward robust and reusable packaging alternatives. One...
Clinical Trials
Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma
In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been...
News
US Levies 15% Tariff on EU for Pharmaceutical Products
The European Union is going to pay the US a tariff rate of 15% when it comes to pharmaceutical products as part of a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read